Asset Details
Do you wish to reserve the book?
Self-assembled single-atom nanozyme for enhanced photodynamic therapy treatment of tumor
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Self-assembled single-atom nanozyme for enhanced photodynamic therapy treatment of tumor
Do you wish to request the book?
Self-assembled single-atom nanozyme for enhanced photodynamic therapy treatment of tumor
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Self-assembled single-atom nanozyme for enhanced photodynamic therapy treatment of tumor
2020
Overview
Hypoxia of solid tumor compromises the therapeutic outcome of photodynamic therapy (PDT) that relies on localized O
2
molecules to produce highly cytotoxic singlet oxygen (
1
O
2
) species. Herein, we present a safe and versatile self-assembled PDT nanoagent, i.e., OxgeMCC-r single-atom enzyme (SAE), consisting of single-atom ruthenium as the active catalytic site anchored in a metal-organic framework Mn
3
[Co(CN)
6
]
2
with encapsulated chlorin e6 (Ce6), which serves as a catalase-like nanozyme for oxygen generation. Coordination-driven self-assembly of organic linkers and metal ions in the presence of a biocompatible polymer generates a nanoscale network that adaptively encapsulates Ce6. The resulted OxgeMCC-r SAE possesses well-defined morphology, uniform size distribution and high loading capacity. When conducting the in situ O
2
generation through the reaction between endogenous H
2
O
2
and single-atom Ru species of OxgeMCC-r SAE, the hypoxia in tumor microenvironment is relieved. Our study demonstrates a promising self-assembled nanozyme with highly efficient single-atom catalytic sites for cancer treatment.
The hypoxic microenvironment in solid tumors limits the efficacy of photodynamic therapy (PDT) since oxygen is necessary to produce high cytotoxic singlet oxygen species. Here, the authors develop an improved self-assembled single-atom nanozyme which allows oxygen generation to enhance PDT efficacy.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 14
/ 14/19
/ 14/34
/ 59/57
/ Animals
/ Catalase
/ Humanities and Social Sciences
/ Humans
/ Hydrogen Peroxide - pharmacology
/ Hypoxia
/ Mice
/ Nanoparticles - therapeutic use
/ Oxygen
/ Photosensitizing Agents - pharmacology
/ Polymers
/ Reactive Oxygen Species - chemistry
/ Reactive Oxygen Species - pharmacology
/ Science
/ Singlet Oxygen - pharmacology
/ Species
/ Tumor Hypoxia - drug effects
/ Tumor Microenvironment - drug effects
/ Tumors
